Medical Marijuana Inc
OTC:MJNA
Medical Marijuana Inc
Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. The company is headquartered in Keizer, Oregon. The company went IPO on 2004-06-21. The Company, through its subsidiaries and investment holdings, focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil (Legal Hemp). The firm's products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale for the treatment of illnesses and conditions, and skin care products. The firm's services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA’s subsidiaries include HempMedsPX, LLC, Red, CanChew Biotechnologies, LLC, Kannaway, LLC, and HempMeds Brazil.
Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. The company is headquartered in Keizer, Oregon. The company went IPO on 2004-06-21. The Company, through its subsidiaries and investment holdings, focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil (Legal Hemp). The firm's products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale for the treatment of illnesses and conditions, and skin care products. The firm's services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA’s subsidiaries include HempMedsPX, LLC, Red, CanChew Biotechnologies, LLC, Kannaway, LLC, and HempMeds Brazil.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.